Clinical Trial Update: A Study in Participants With Non-cirrhotic NASH With Fibrosis [Phase 2]

View source ↗

Summary

This Phase 2 trial update from AstraZeneca reports results for non-cirrhotic non-alcoholic steatohepatitis with fibrosis, with results posted on 2025-07-09.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Snippet

Sponsor: AstraZeneca | Conditions: Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2025-07-09